Radial vs. Femoral Access for Cardiac Catheterization Complications
(REBIRTH Trial)
Trial Summary
What is the purpose of this trial?
This trial compares two methods for inserting a tube into heart blood vessels in patients needing heart checks. One method uses the wrist, and the other uses the groin. The goal is to find out which method is better.
Will I have to stop taking my current medications?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking oral factor Xa or IIa inhibitors, you should not have taken them within 24 hours before the procedure.
What data supports the effectiveness of the treatment Radial Access, State-of-the-art femoral access with 18 gauge needle, and State-of-the-art femoral access with 21 gauge needle for cardiac catheterization complications?
Is radial or femoral access for cardiac catheterization generally safe?
Radial access for cardiac catheterization is generally considered safer than femoral access, with fewer and less severe complications. However, radial artery occlusion and rare complications like pseudoaneurysms can occur. Femoral access, while necessary for some procedures, may have more vascular complications, but using ultrasound guidance can help reduce these risks.13456
How does radial access for cardiac catheterization differ from femoral access?
Radial access for cardiac catheterization is unique because it generally results in fewer bleeding complications compared to the traditional femoral access, although it may have a higher rate of access site failure. This approach is considered safer for patients at risk of femoral complications, and ongoing improvements in the technique are expected to enhance outcomes further.35789
Research Team
Emmanouil Brilakis, MD, PhD
Principal Investigator
Minneapolis Heart Institute Foundation
Eligibility Criteria
Adults over 18 eligible for cardiac catheterization via both radial and femoral access, who consent to participate. Suitable for those needing diagnostic angiography or urgent/elective PCI, but not for patients with recent oral anticoagulant use, peripheral arterial disease affecting access sites, limited life expectancy, certain heart conditions or procedures within the next month.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cardiac catheterization using either radial or state-of-the-art femoral access
Follow-up
Participants are monitored for safety and effectiveness after the procedure, including evaluations of myocardial infarction and procedural success
Treatment Details
Interventions
- Radial Access (Procedure)
- State-of-the-art femoral access with 18 gauge needle (Procedure)
- State-of-the-art femoral access with 21 gauge needle (Procedure)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Minneapolis Heart Institute Foundation
Lead Sponsor